Wordt geladen...
Pharmacogenetics of Tamoxifen: CYP2D6 Testing in Breast Cancer - Ready for Prime Time?
Despite recent advances in hormonal therapy for breast cancer, tamoxifen remains a major therapeutic option, with indications ranging from primary prevention to metastatic disease. Understanding the variation in response to tamoxifen may significantly improve our ability to personalize cancer care a...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3651736/ https://ncbi.nlm.nih.gov/pubmed/20120834 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|